from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3492c/-

LFCtreatmentdescriptionclass of inhibitor

-0.183

Amikacinug/mL Amikacintranslation

-0.169

Cap5-10ug/mL Capreomycintranslation

-0.740

Rox10-50 ug/mL Roxithromycintranslation

-0.428

SM2-5 ug/mL Streptomycintranslation

-0.001

Tet5-10 ug/mL Tetracyclinetranslation

-0.105

Rif0.2-5ug/mL Rifampicintranscription

0.590

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.485

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.737

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.033

CPZ10-50 ug/mL Chlorpromazinerespiration

0.067

Clofazimine10-13 ug/mL Clofaziminerespiration

0.588

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.275

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.851

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.378

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.668

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.047

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.360

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.108

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.773

KCN5-20 ug/mL Potassium cyaniderespiration

0.133

NaN30.2-2 mM Sodium aziderespiration

-0.159

Nigericin50 uM Nigericinrespiration

0.301

TRC10-150 ug/mL Triclosanrespiration

-0.122

TRZ10-25 ug/mL Thioridazinerespiration

-1.738

Valinomycin0.5-10 uM Valinomycinrespiration

-0.652

ZnSO42 mM ZnSO4respiration

0.145

menadione6-10 ug/mL Menadionerespiration

0.331

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.150

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.633

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.035

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.867

NRP_1Non-replicating persistence stage 1dosRassociated

-0.498

Amp0.2mg/mL AmpicillincellWall

0.041

Cephalexin20-100 ug/mL CephalexincellWall

-0.120

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.089

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.086

EMB10-20 ug/mL EthambutolcellWall

-0.351

Eta12-40 ug/mL EthionamidecellWall

0.009

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.175

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.800

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.455

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.077

BZA0.12 mg/mL BenzamidearomaticAmides

0.113

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.075

H2O24 mM hydrogen peroxideDNAdamaging

-0.027

Levo10 ug/mL LevofloxacinDNAdamaging

0.228

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.295

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.198

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.129

UVUV-irradiationDNAdamaging

0.501

ARP41-4 ug/mL Antitubercular compound ARP4?

0.809

Antimycin12.5-50 ug/mL Antimycin A?

0.235

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.042

PA_110-50 ug/mL Antitubercular compound PA-1?

1.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.693

PA8240.2-2 ug/mL PA-824?

-0.829

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.355

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.812

Verapamil50 uM Verapamil?

-0.558

mercaptoethanol2 mM 2-Mercaptoethanol?

0.347

methoxatin10-20 ug/mL Methoxatin?